Erythromycin Ethylsuccinate
- Product NDC
- 60219-1504
- 11-digit product format
- 602191504
- Labeler code
- 60219
- Product ID
- 60219-1504_0488543c-588b-4b75-acb3-4999aa84ebfc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA211204
- Marketing category
- ANDA
- Marketing start
- 2023-12-02
- Substance
- ERYTHROMYCIN ETHYLSUCCINATE
- Active strength
- 400 mg/5mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Erythromycin Ethylsuccinate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ERYTHROMYCIN ETHYLSUCCINATE | 400 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1014KSJ86F |
| Rxcui | 686400, 686418 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60219-1504-2 | Erythromycin Ethylsuccinate | 100 mL in 1 BOTTLE | SUSPENSION | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60219-1504 | ERYTHROMYCIN ETHYLSUCCINATE (ERYTHROMYCIN) SUSPENSION [AMNEAL PHARMACEUTICALS NY LLC] | 2 | Current NDC, 1 package rows | 20250427_581d7430-1a80-42a6-befb-4c3ae8140392.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 60219-1504-2 | 60219150402 | 100 mL in 1 BOTTLE (60219-1504-2) | 100 ml | 2023-12-02 | No | No | Current |